Target Price | $2,440.00 |
Price | $0.53 |
Potential |
460,364.00%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Aditx Therapeutics Inc price target 2025.
The average Aditx Therapeutics Inc target price is $2,440.00.
This is
460,364.00%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Aditx Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aditx Therapeutics Inc stock has an average upside potential 2025 of
460,364.00%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.65 | 1.48 |
30.11% | 126.92% | |
Net Margin | -33,277.85% | -12,312.37% |
939.41% | 63.00% |
1 Analyst has issued a sales forecast Aditx Therapeutics Inc 2024 . The average Aditx Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
2023 | $650k | 30.11% |
---|---|---|
2024 |
$1.5m
126.92%
Unlock
|
The average Aditx Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
2023 | $-216m | 626.47% |
---|---|---|
2024 |
$-182m
16.04%
Unlock
|
2023 | -33,277.85% | 939.41% |
---|---|---|
2024 |
-12,312.37%
63.00%
Unlock
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -4,326.12 | -91.26 |
626.47% | 97.89% | |
P/E | 0.00 | |
EV/Sales | 6.31 |
The average Aditx Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
2023 | $-4,326.12 | 626.47% |
---|---|---|
2024 |
$-91.26
97.89%
Unlock
|
Current | 0.00 | 100.00% |
---|
Based on analysts' sales estimates for 2024, the Aditx Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current | 37.45 | 419.42% |
---|---|---|
2024 |
6.31
83.15%
Unlock
|
Current | 14.03 | 880.04% |
---|---|---|
2024 |
1.07
92.37%
Unlock
|
Aditx Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.